Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,718 | 17,158 | 22,602 | 2,392 | 4,973 |
| Receivables | 7 | 8 | 10 | 9 | 10 |
| Other current assets | 500 | 0 | 0 | 94 | 0 |
| TOTAL | $16,588 | $17,717 | $22,955 | $2,851 | $5,099 |
| Non-Current Assets | |||||
| PPE Net | 165 | 172 | 175 | 0 | N/A |
| Intangibles | 0 | 0 | 1 | 2 | 4 |
| Other Non-Current Assets | 2,100 | 2,600 | 0 | 85 | 0 |
| TOTAL | $2,265 | $2,772 | $176 | $87 | $4 |
| Total Assets | $18,853 | $20,489 | $23,131 | $2,938 | $5,102 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,030 | 2,254 | 1,948 | 2,675 | 1,382 |
| TOTAL | $2,533 | $2,727 | $2,389 | $2,675 | $1,382 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 202 | 177 | 188 | 0 | 0 |
| TOTAL | $202 | $177 | $188 | $N/A | $N/A |
| Total Liabilities | $2,735 | $2,904 | $2,577 | $2,675 | $1,382 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19 | 18 | 14 | N/A | 7 |
| Common Shares | 32 | 25 | 24 | 11 | 11 |
| Retained earnings | -104,489 | -97,846 | -92,427 | -69,721 | -65,894 |
| Other shareholders' equity | 21 | 21 | 21 | 21 | 8,404 |
| TOTAL | $16,118 | $17,585 | $20,554 | $263 | $3,721 |
| Total Liabilities And Equity | $18,853 | $20,489 | $23,131 | $2,938 | $5,102 |